Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments
- •Introduction
- •Contents
- •Contributors
- •Risk Factors
- •Prevention
- •Chemoprophylaxis
- •Preoperative Chemoprophylaxis
- •Mechanical Prophylaxis
- •Early Mobilization
- •Extended Postoperative Chemoprophylaxis
- •Prophylactic IVC Filters
- •Diagnosis
- •Imaging
- •Treatment
- •Therapeutic Anticoagulation
- •Medication Options
- •IVC Filter Placement
- •References
- •1: Perioperative Venous Thromboembolism
- •Background
- •Epidemiology
- •Preoperative Considerations
- •Intraoperative Considerations
- •Postoperative Considerations
- •Future Directions
- •Thromboembolic Events
- •Prehabilitation
- •Immunonutrition
- •Summary
- •References
- •3: Frailty
- •Frailty
- •Assessing Frailty
- •Interventions Following Frailty Assessment
- •Conclusion
- •References
- •Introduction
- •(Neo)Adjuvant Therapy
- •Conclusions
- •References
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Perforation
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •6: Hysterectomy
- •Introduction
- •Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Injury
- •Background
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Postoperative Considerations
- •Prolapse Recurrence
- •Conclusion
- •References
- •Prevention
- •Recognition
- •Management
- •References
- •7: Genital Tract Prolapse
- •Intraoperative Injuries
- •Vascular Injury
- •Background
- •Introduction
- •Injectable Therapy
- •An Overview
- •Complications
- •Retention
- •De Novo Irritative Voiding Symptoms
- •Mid-Urethral Slings (MUS)
- •An Overview
- •Tension-Free Vaginal Tape (TVT)
- •Transobturator Tape (TOT)
- •Single-Incision Slings (SIS)
- •Complications
- •Mesh Erosion
- •Bladder Injury
- •Pain
- •Voiding Dysfunction
- •De Novo Irritative Voiding Symptoms
- •Recurrent Incontinence
- •Pubovaginal Slings (PVS)
- •An Overview
- •Complications
- •Bladder Perforation
- •Urinary Retention
- •De Novo Irritative Voiding Symptoms
- •Recurrent Incontinence
- •Retropubic Suspensions
- •An Overview
- •Complications
- •Voiding Dysfunction
- •Recurrent Incontinence
- •Conclusions
- •References
- •9: Urethral Diverticulectomy
- •Diagnosis
- •Surgical Management
- •Complications Following Urethral Diverticulectomy
- •Stress Urinary Incontinence
- •De Novo SUI
- •Urethrovaginal Fistula
- •Urethral Stricture
- •Recurrent Urethral Diverticulum
- •Conclusions
- •References
- •10: Segmental or Total Female Urethrectomy
- •Meatotomy
- •Stress Urinary Incontinence (SUI) After Partial Urethrectomy
- •Pubovaginal Slings (PVSs)
- •Pubovaginal Sling Erosion
- •References
- •11: Transurethral Bladder Surgery
- •Introduction
- •Bladder Perforation
- •Cystitis: Infection/Urinary Tract Infection (UTI)
- •Summary
- •References
- •12: Partial Cystectomy
- •Introduction
- •Preoperative Workup
- •Surgical Technique
- •Complications
- •Oncological Outcomes
- •Conclusions
- •References
- •Introduction
- •Surgical Approach
- •Complications by Category
- •Genitourinary
- •Infection
- •Gastrointestinal
- •Cardiopulmonary
- •Bleeding/Thromboembolic
- •Neurological
- •Cerebrovascular Accident/Stroke
- •Delirium/Agitation
- •Miscellaneous
- •Lymphocele
- •Organ-Sparing Cystectomy (Uterus-, Fallopian Tube-, Ovary-Sparing)
- •Ovary Removal Risks (Bone Loss, Fracture Risk, Cardiac Events, Cognitive Decline, Mortality)
- •Vaginal Complications
- •References
- •14: Complications in Orthotopic Neobladders
- •Introduction
- •Early Postoperative Complications
- •Long-Term Complications
- •Conclusions
- •References
- •Introduction
- •Ileocecal Reservoirs
- •Colonic Reservoirs
- •Ileal Reservoirs
- •Conclusions
- •References
- •Introduction
- •Stoma-Related Complications
- •Parastomal Hernia
- •Stomal Stenosis
- •Ureterointestinal Stricture
- •Infection
- •Enterocutaneous Fistula
- •Anastomotic Leak
- •Conduit Necrosis
- •Metabolic Disturbances
- •Additional Thoughts
- •References
- •Background
- •Management
- •References
- •18: Ureteroscopy
- •Introduction
- •Intraoperative Complications
- •Ureteral Wall Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Bleeding
- •Background
- •Prevention
- •Management
- •Early Postoperative Complications
- •Vascular Anomalies
- •Background
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Stent Discomfort
- •Premature Labor
- •Ureteral Stent Migration
- •Background
- •Prevention
- •Recognition
- •Management
- •Intravascular Stent Misplacement
- •Post-Obstructive Diuresis
- •Late Postoperative Complications
- •Ureteral Strictures
- •Background
- •Prevention
- •Recognition
- •Management
- •Neglected Stents
- •Background
- •Prevention
- •Recognition
- •Management
- •Conclusions
- •References
- •Introduction
- •Perforation
- •Background
- •Prevention
- •Recognition
- •Management
- •Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Abscesses
- •Background
- •Prevention
- •Recognition
- •Management
- •Strictures
- •Background
- •Prevention
- •Recognition
- •Management
- •Fecal Incontinence
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Retention
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •Cryptoglandular Pathophysiology—Abscess
- •Fistula-in-Ano
- •Fistulotomy
- •Seton Placement
- •Fistula Plugs/Fibrin Glue
- •Endorectal Advancement Flap (ERAF)
- •Minimally Invasive Approaches
- •Mesenchymal Stem Cell (MSC) Therapy
- •Complex Advanced Fistula Therapy
- •Conclusions
- •References
- •21: Fecal Incontinence
- •Treatment
- •Anal Insertion Devices
- •Vaginal Bowel Control Systems
- •Bulking Agents
- •Radio-Frequency Tissue Remodeling (SECCA®)
- •Percutaneous Tibial Nerve Stimulation (PTNS)
- •Sacral Nerve Neuromodulation (SNM)
- •Surgical Sphincter Repair (Sphincteroplasty)
- •Ventral Mesh Rectopexy (VMR)
- •Other Treatments
- •References
- •General Background
- •Preoperative Procedural Considerations
- •General Abdominal Surgery Complications
- •Hemorrhagic Complications During Rectopexy
- •Mesh Complications
- •Discitis
- •Intra-Abdominal Collections/Seromas/Abscesses
- •Ureteral Injury
- •Bowel Obstruction
- •Anastomotic Leaks
- •Postoperative Pain
- •Perineal Surgery
- •Multicompartment Prolapse Repairs
- •Postoperative Constipation/Fecal Impaction
- •Conclusions
- •References
- •Background
- •Prevention
- •Recognition
- •Vascular Injury
- •Bowel Injury
- •Management
- •Major Vascular Injury
- •Carbon Dioxide Embolism
- •Bowel Injury
- •Background
- •Recognition
- •Incision Site Hernia
- •Background
- •Recognition
- •Respiratory Mechanics
- •Preoperative Evaluation
- •Positioning
- •Trendelenburg Complications
- •Cardiopulmonary
- •Ocular Complications
- •Peripheral Nerve Injury
- •References
- •Background
- •Diagnosis
- •Treatment
- •The General Surgical Approach
- •Nerve-Sparing Surgery
- •Bladder Endometriosis
- •Diagnosis
- •Treatment
- •Ureteral Endometriosis (UE)
- •Diagnosis
- •Treatment
- •Ureteral Complications
- •Diagnosis
- •Surgical Treatment
- •Shaving Excision
- •Laparoscopic Disk Excision
- •Segmental Resection
- •Bowel Complications
- •Conclusions
- •References
- •Introduction
- •Intraoperative Complications
- •Early Postoperative Complications
- •Surgical Site Infections
- •Late Postoperative Complications
- •Anastomotic/Pouch Fistulas
- •Infertility
- •Sexual Dysfunction
- •Unhealed Perineal Wound
- •Entrapped Ovary (Inclusion Cyst)
- •Summary
- •References
- •Introduction
- •Genitourinary Complications
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Neurologic Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •27: Cesarean Section
- •Introduction
- •Postpartum Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Unintended Hysterotomy Extension
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Scar Dehiscence
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Inversion
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Post-Cesarean Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •28: Management of Ectopic Pregnancy and Surgical Considerations
- •Background
- •Tubal Ectopic Pregnancy
- •Prevention
- •Laparoscopy Versus Laparotomy
- •Recognition
- •Massive Hemorrhage, Hemodynamic Instability
- •Nondiagnostic Laparoscopy
- •Management
- •Hemoperitoneum
- •Nontubal Ectopic Pregnancy
- •Prevention
- •Recognition
- •Management
- •Interstitial
- •Ovarian
- •References
- •29: Surgical Abortion
- •Introduction
- •Hemorrhage
- •Uterine Atony
- •Background
- •Prevention
- •Recognition
- •Management
- •Abnormal Placentation
- •Background
- •Prevention
- •Acute Coagulopathy
- •Background
- •Prevention
- •Recognition
- •Management
- •Cervical Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Conclusions
- •References
- •30: Cesarean Hysterectomy
- •Introduction
- •Obstetric Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Surgical Site Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Massive Obstetric Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Disseminated Intravascular Coagulopathy (DIC)
- •Background
- •Prevention
- •Recognition
- •Management
- •Urologic Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •31: Inguinal Lymphadenectomy, Radical Vulvectomy
- •References
- •Introduction
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Lymphedema
- •Background
- •Prevention
- •Recognition
- •Management
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Duodenum
- •Background
- •Prevention
- •Recognition
- •Management
- •Arterial Embolization
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Management
- •References
- •33: Radical Hysterectomy
- •Introduction
- •Ureteral Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Rectal Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •Colorectal Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •Surgical Site Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Sexual Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Post-Operative Bleeding/Hematoma
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Leak
- •Background
- •Prevention
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Stricture
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •35: Anal Cancer
- •Introduction
- •Perineal Wound Infection/Dehiscence
- •Background
- •Prevention
- •Recognition
- •Management
- •Acute
- •Chronic
- •Pelvic Fluid Collections/Abscesses/Organ Space Infections
- •Background
- •Prevention
- •Recognition
- •Management
- •Perineal Hernia
- •Background
- •Prevention
- •Recognition
- •Management
- •Small Bowel Obstruction
- •Background
- •Prevention
- •Recognition
- •Management
- •Large Bowel Obstruction
- •Background
- •Prevention
- •Recognition
- •Management
- •Fecal Incontinence
- •Background
- •Prevention
- •Recognition
- •Management
- •Rectovaginal Fistula
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Enteritis
- •Background
- •Prevention
- •Recognition
- •Management
- •Sigmoid Stricture Formation
- •Background
- •Prevention
- •Recognition
- •Management
- •Conclusion
- •References
- •Introduction
- •Anastomotic Leak
- •Background
- •Prevention
- •Recognition
- •Management
- •AL Requiring Operative Intervention
- •Endosponge
- •Local Repairs
- •Anastomotic Stricture
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Presacral Venous Bleeding
- •Background
- •Recognition
- •Prevention
- •Management
- •Low Anterior Resection Syndrome
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Treatment
- •References
- •37: Pelvic Radiation Therapy
- •Introduction
- •External Beam Radiation Therapy
- •Brachytherapy
- •Radiotherapy Toxicity
- •Toxicities by System
- •Bladder/Ureters/Urethra
- •Background
- •Prevention
- •Recognition
- •Management
- •Small Bowel
- •Background
- •Prevention
- •Recognition
- •Management
- •Colon/Rectum
- •Background
- •Prevention
- •Recognition
- •Management
- •Anus/Vulva/Skin
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterus
- •Background
- •Prevention
- •Recognition
- •Management
- •Ovaries
- •Background
- •Prevention
- •Recognition
- •Management
- •Vagina
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular/Lymphatics/Nerves
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •38: Pelvic Exenteration for Central Pelvic Cancer
- •Introduction
- •Pre-Operative Considerations
- •Intra-Operative Complications
- •WHO Checklist
- •Post-Operative Complications
- •Immediate
- •Conclusion
- •References
- •Introduction
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Summary
- •References
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Hardware Failure/Mechanical Complications
- •Background
- •Prevention
- •Recognition
- •Management
- •Pelvic Cancer Complications Involving Bone
- •Osteomyelitis
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Osteitis
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Associated Sarcomas
- •Background
- •Prevention
- •Recognition
- •Management
- •Wound Healing Considerations
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •41: Pelvic Reconstructive Procedures
- •Background
- •Prevention
- •Preoperative
- •Intraoperative
- •Postoperative
- •Recognition
- •Fluid Collection
- •Infection
- •Partial or Total Flap Loss
- •Fistula
- •Donor Site Complications
- •Management
- •Fluid Collection
- •Infection
- •Partial or Total Flap Loss
- •Fistula
- •Donor Site Complications
- •Conclusion
- •References
- •Index

92
L. M. Conroy and O. L. Westney
urodynamic stress urinary incontinence: efcacy and adverse effects at 13-years follow-up.
Neurourol Urodyn. 2020;39(5):1423–9. https://doi.
org/10.1002/nau.24358.
21. Kokanali MK, Doğanay M, Aksakal O, Cavkaytar S,
Topçu HO, Özer İ. Risk factors for mesh erosion after
vaginal sling procedures for urinary incontinence. Eur
J Obstet Gynecol Reprod Biol. 2014;177:146–50.
https://doi.org/10.1016/j.ejogrb.2014.03.039.
22. de Leval J.Novel surgical technique for the treatment
of female stress urinary incontinence: transobturator
vaginal tape inside-out. Eur Urol. 2003;44(6):724–30.
https://doi.org/10.1016/j.eururo.2003.09.003.
23. Richter HE, Albo ME, Zyczynski HM, Kenton K,
Norton PA, Sirls LT, et al. Retropubic versus transobturator midurethral slings for stress incontinence.
N Engl J Med. 2010;362(22):2066–76. https://doi.
org/10.1056/NEJMoa0912658.
24. Schierlitz L, Dwyer PL, Rosamilia A, Murray C,
Thomas E, De Souza A, etal. Three-year follow-up
of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence
and intrinsic sphincter deciency. Obstet Gynecol.
2012;119(2 Pt 1):321–7. https://doi.org/10.1097/
AOG.0b013e31823dfc73.
25. Mock S, Angelle J, Reynolds WS, Osborn DJ,
Dmochowski RR, Gomelsky A. Contemporary
comparison between retropubic midurethral sling
and autologous pubovaginal sling for stress urinary
incontinence after the FDA advisory notication.
Urology. 2015;85(2):321–5. https://doi.org/10.1016/j.
urology.2014.10.017.
26. Plagakis S, Tse V.The autologous pubovaginal fascial
sling: an update in 2019. Low Urin Tract Symptoms.
2020;12(1):2–7. https://doi.org/10.1111/luts.12281.
27. Niknejad K, Plzak LS, Staskin DR, Loughlin
KR. Autologous and synthetic urethral slings
for female incontinence. Urol Clin North Am.
2002;29(3):597–611. https://doi.org/10.1016/
s0094- 0143(02)00074- 5.
28. Dmochowski RR, Blaivas JM, Gormley EA, Juma
S, Karram MM, Lightner DJ, etal. Update of AUA
guideline on the surgical management of female stress
urinary incontinence. J Urol. 2010;183(5):1906–14.
https://doi.org/10.1016/j.juro.2010.02.2369.
29. Athanasopoulos A, Gyftopoulos K, McGuire
EJ. Efcacy and preoperative prognostic factors of autologous fascia rectus sling for treatment
of female stress urinary incontinence. Urology.
2011;78(5):1034–8. https://doi.org/10.1016/j.
urology.2011.05.069.
30. Kim S, Wong DG, Lee D, Christie AL, Zimmern
PE.Very long-term follow-up of autologous pubovaginal fascia slings in women with stress urinary incontinence. Int Urogynecol J. 2022;33(4):821–8. https://
doi.org/10.1007/s00192- 021- 04737- 7.
31. Khan ZA, Nambiar A, Morley R, Chapple CR, Emery
SJ, Lucas MG.Long-term follow-up of a multicentre
randomised controlled trial comparing tension-free
vaginal tape, xenograft and autologous fascial slings
for the treatment of stress urinary incontinence in
women. BJU Int. 2015;115(6):968–77. https://doi.
org/10.1111/bju.12851.
32. Shariaghdas F, Mirzaei M, Daneshpajooh A, Narouie
B.Long-term results of tension-free vaginal tape and
pubovaginal sling in the treatment of stress urinary
incontinence in female patients. Clin Exp Obstet
Gynecol. 2017;44(1):44–7.
33. Hartigan SM, Chapple CR, Dmochowski
RR.Retropubic suspension surgery for incontinence
in women Campbell-Walsh-Wein urology. 12th ed.
Elsevier Inc.; 2021. p.2756–75.
34. Burch JC. Urethrovaginal xation to Cooper’s ligament for correction of stress incontinence, cystocele,
and prolapse. Am J Obstet Gynecol. 1961;81:281–90.
https://doi.org/10.1016/s0002- 9378(16)36367- 0.
35. Freites J, Stewart F, Omar MI, Mashayekhi A,
Agur WI. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database
Syst Rev. 2019;12(12):CD002239. https://doi.
org/10.1002/14651858.CD002239.pub4.
36. Lapitan MCM, Cody JD, Mashayekhi A. Open
retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst
Rev. 2017;7(7):CD002912. https://doi.
org/10.1002/14651858.CD002912.pub7.
37. Brubaker L, Richter HE, Norton PA, Albo M,
Zyczynski HM, Chai TC, et al. 5-year continence
rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. J Urol. 2012;187(4):1324–30. https://doi.
org/10.1016/j.juro.2011.11.087.
38. Albo ME, Richter HE, Brubaker L, Norton P, Kraus
SR, Zimmern PE, etal. Burch colposuspension versus fascial sling to reduce urinary stress incontinence.
N Engl J Med. 2007;356(21):2143–55. https://doi.
org/10.1056/NEJMoa070416.

Urethral Diverticulectomy
RichardLee andLeoDreyfuss
9
Pathophysiology ofaUrethral
Diverticulum (UD)
The exact etiology of a urethral diverticulum is
unclear. While there are reports of congenital
urethral diverticula in females and males, it is
accepted that most urethral diverticula are
acquired in adulthood [1, 2]. Urethral diverticula
are thought to arise from the periurethral glands,
located in the posterolateral mid- to distal urethra. The pathophysiologic process behind the
formation of urethral diverticula is likely related
to infection, which can lead to abscess formation
within the periurethral glands. Recurrent infection causes submucosal tracking of the abscess
within the periurethral fascia, which eventually
ruptures into the urethral lumen, creating the
characteristic ostium.
The most common location of urethral diverticula is the distal two-thirds of the ventral urethra. This corresponds to the location of most
periurethral glands, supporting the aforementioned pathophysiologic hypothesis (Fig. 9.1).
One-third of diverticula, however, are found in
the proximal portion of the urethra, and expansion of the diverticula can occur anteriorly or
extend circumferentially [3].
Surgical pathology following excision most
often reveals a benign histology, although inammatory changes are common. Premalignant
changes can be seen in 10–20% of specimens.
Malignancy within a urethral diverticulum is
rare. Adenocarcinoma is the most common
malignant pathology seen, in contrast to urethral
carcinoma, where squamous cell carcinoma is
more common [4, 5]. Urethral diverticula may
contain stones caused by urinary stasis. Their
size and location are variable; urethral diverticula
can extend anywhere within the periurethral fascia, and may extend circumferentially or in a
horseshoe orientation. Multiple diverticula may
be present [5, 6].
R. Lee (*) · L. Dreyfuss
Department of Urology, Weill Cornell Medical
College, New York Presbyterian Hospital,
New York, NY, USA
e-mail: ril9010@med.cornell.edu; ldd9009@nyp.org
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025
M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5_9
93

94
Diver
diverticulum
Fig. 9.1 Sagittal view
of the female pelvis with
the urethral diverticulum
distal to the urethral
sphincter. Adapted from
EAU 2016 [51]
R. Lee and L. Dreyfuss
Urethra
Urethral
sphincter
Os of
ticulum
Periurethral
fascia
Prevalence andPresentation
Presentation is variable. Patients tend to be in the
third to sixth decade of life. Incidence is estimated to be between 1 and 6% [7, 8]. The most
common presenting symptoms are a vaginal
lump, pain in the area of the diverticulum, dysuria, and dyspareunia. Post-void dribbling, recurrent urinary tract infections (UTIs), and urethral
discharge can also be present [9, 10]. The classic
“three D’s” (discharge, dyspareunia, and dribbling) are found in only 5% of patients [11].
Diagnosis
According to Davis and Telinde, “The most
important single diagnostic instrument for the
discovery of suburethral diverticula is a high
index of suspicion” [12]. Patients presenting with
Urethral
Vagina Rectum
the above symptoms should undergo a thorough
history and physical exam. Physical exam may
reveal a uctuant bulge over the anterior vaginal
wall. Occasionally, rm palpation of this mass
may result in expression of purulent debris from
the urethra. Urine studies should be obtained and
sent for culture to guide perioperative
antimicrobial coverage. Cystourethroscopy can
be performed to visualize the ostium of the diverticulum. Multiple ostia may be present and are
commonly located posterolaterally at the 4 and 8
o’clock position but can be visualized in a minority of patients.
Numerous imaging studies have been
employed in the diagnosis of urethral diverticula.
Double balloon positive pressure urethrography
(PPU) is considered the historic gold standard for
diagnosis and characterization of UDs but is
rarely used. If the patient is able to void, a voiding cystourethrogram (VCUG) can be used to

9 Urethral Diverticulectomy
95
diagnose the presence of a UD, which will
opacify with contrast during voiding.
Transvaginal ultrasound can provide useful information regarding the size and location of a UD
but is operator-dependent and does not produce
detailed images. Magnetic resonance imaging
(MRI) is commonly employed as the standard
imaging modality for diagnosis of UDs with
good performance compared to the gold standard
PPU [13].
Dierential Diagnosis
Periurethral masses that may be mistaken for urethral diverticula include vaginal leiomyoma,
Skene’s gland abnormalities, Gartner duct abnormalities, vaginal wall cysts, urethral prolapse,
urethral caruncle, or periurethral bulking agents.
Careful history and physical exam can help differentiate urethral diverticula from these distinct
entities [3].
Indications forRepair
Excision of urethral diverticula may be offered to
symptomatic patients who desire surgical intervention. It is important to counsel patients whose
primary complaint is pain that concurrent conditions, particularly pelvic oor dysfunction or
lower urinary tract symptoms (LUTSs), may
exist and may not resolve following diverticulectomy. While progression to carcinoma has been
reported, it is considered a rare entity; prophylactic urethral diverticulectomy in an asymptomatic
patient for the sole intent of avoiding a malignancy is not necessary. However, patients who
desire nonoperative management must be counseled on the low risk of malignancy, which may
not be seen on diagnostic imaging [4, 5, 14].
Conservative management is an option for
patients with UDs; recurrent UTIs and stress urinary incontinence (SUI) can be managed with
prophylactic antibiotics and pelvic oor physical
therapy (PFPT), respectively, but no guidance
exists for periodic screening of patients with urethral diverticula for malignancy.
Surgical Management
Multiple surgical techniques for the management of urethral diverticula have been reported
[15–18]. Currently, the two most widely used
techniques are transvaginal marsupialization
and excision and reconstruction, with the latter
being far more common. Despite the overwhelming popularity of this technique, there is
insufcient evidence to compare differences in
outcomes and complications between various
procedures [19].
Transvaginal marsupialization is an option
for distal urethral diverticula. Originally
described by Spence and Duckett, marsupialization may be faster and lead to less blood
loss than excision and reconstruction. Briey,
the procedure involves placement of one blade
of a Metzenbaum scissors into the urethra and
incision into the diverticulum and anterior vaginal wall to create a “generous meatotomy”
[16]. However, extension of the incision too far
proximally may lead to damage of the external
sphincter and cause incontinence or to development of a “pseudoseptum” between the urethra and anterior bladder wall. This may cause
dyspareunia and limit the classic marsupialization technique to the distal diverticula in
patients who are not sexually active. Recently,
a variation of the Spence and Duckett procedure has been described for distal diverticula
involving an incision directly on the diverticular ostium followed by marsupialization,
allowing the area to drain into the vagina. This
technique may offer the benets of the traditional Spence and Duckett technique while
minimizing the risks of long-term dyspareunia
or incontinence [20].
For patients with complicated urethral diverticula, such as those undergoing repeat surgeries,
or for those with complex or circumferential
diverticula, variations in surgical technique have
been described with favorable results. These
include use of xenogenic grafts, lateral vaginal
aps, urethroplasty with remnants of the diverticular sac, end-to-end urethroplasty following
diverticulectomy, and the transabdominal robotassisted laparoscopic approach [21–24].

96
Urethral suture
R. Lee and L. Dreyfuss
Excision andReconstruction
Excision and reconstruction is the most commonly used technique for excision of urethral
diverticula, although there is insufcient evidence to compare the rates of complications and
outcomes between different techniques [19].
Basic surgical principles can be employed to
optimize outcomes and minimize complications;
vaginal wall aps dissected out with preserved
blood supply, periurethral fascia preserved as
separate layer, and the ostium neck and diverticulum wall completely excised. Closure should be
performed in a watertight manner with minimal
overlapping of sutures. Topical estrogen can be
administered for 4–6weeks preoperatively if the
patient is postmenopausal to improve vascular
supply to the tissue. Preoperative, culture- specic
antibiotics should be given if the patient has a
history of recurrent urinary tract infections.
The procedure is carried out in the dorsal
lithotomy position with a Foley catheter placed.
An inverted-U incision is made with special consideration to make the proximal portion of the
“U” (toward the bladder neck) wide to preserve
proximal blood supply. During dissection, the
periurethral facia should be preserved as it is an
essential layer to close with following removal of
diverticular sac. Once the periurethral tissue
plane around the diverticulum is developed, a
horizontal incision can be made on the diverticulum taking care to not violate the sac. The
diverticulum is then dissected free of the periurethral tissue to the ostium origin on the urethra and
then excised. The entire mucosal surface of the
diverticulum should be removed in order to prevent recurrence. Following excision, the Foley
catheter can be seen through the defect and a
tension- free closure is performed using multiple
layers of absorbable sutures (Fig.9.2). Following
Vaginal
wall suture
Periurethral
fascia suture
Fig. 9.2 Diagram of a multilayered closure of (from deep to supercial) a urethral defect, the periurethral fascia, and
the vaginal epithelium. The minimal overlapping of suture lines should be noted. Adapted from Ref. [52]

9 Urethral Diverticulectomy
97
closure, the Foley catheter is removed and diluted
methylene blue is gently injected into the urethra
with a catheter tip syringe to ensure watertight
closure.
It is essential to avoid dead space by securing
the periurethral fascial aps. Deep to the vaginal
wall, brofatty labial aps can be used to prevent
risk of wound breakdown or stula with a low
rate of complication. Use of a Martius ap is safe
but can result in pain, dyspareunia, hematoma, or
abscess requiring drainage [25–27].
Complications Following Urethral Diverticulectomy
Short-term complications (<30 days) following
urethral diverticulectomy include urinary tract
infections (1–10%), soft tissue infections (<1%),
and bleeding requiring transfusion (<1%)
[28–30].
Long-term complications include lower urinary tract symptoms (frequency, dysuria, 10%)
and pain (11%). There have been reports of an
overactive bladder following urethral diverticulectomy, which can be managed with medical
therapy [29, 31]. De novo SUI can occur in up to
17% of patients following urethral diverticulectomy [10, 32]. Vesicovaginal stulas and urethral
strictures are rare outcomes following surgery
[23, 30, 33]. Residual or recurrent urethral diverticula are found at rates as high as 10–16% postoperatively, and this is related to the complexity
of the diverticulum [3, 6, 34–36].
Stress Urinary Incontinence
Stress urinary incontinence deserves special
attention in the context of UD as one of the hallmark symptoms of UD, post-void dribbling can
easily be mistaken for SUI.SUI can also be diag-
nosed as a separate entity during preoperative
evaluation. It can also arise de novo as a complication of diverticulectomy. It is important to discuss SUI separately in the context of each of
these distinct presentations.
Concurrent SUI withaUrethral
Diverticulum
For patients who present with SUI in the setting of a urethral diverticulum, an accurate
diagnosis is important, as leakage of accumulated urine from the diverticulum can be mistaken for SUI. Diagnosticians can manually
empty out the diverticulum and ask the patient
to cough as a means of elucidating the presence of SUI [37].
Urodynamic evaluation can be conducted
preoperatively to delineate symptomatology in
patients with a urethral diverticulum. Video urodynamics (VUD) is preferred as a voiding cystourethrogram (VCUG) can allow for
visualization of the diverticulum. SUI can be
found during urodynamic evaluation in up to
50% of patients presenting with a urethral diverticulum [29, 38].
Patients who present preoperatively with SUI
may be offered anti-incontinence surgery at the
time of diverticulectomy. It is also reasonable to
defer treatment of SUI and reevaluate symptoms
following diverticulectomy. A retrospective analysis by Greiman etal. showed that 8 of 15 patients
who underwent urethral diverticulectomy without simultaneous placement of an autologous
pubovaginal sling saw resolution of SUI following surgery, compared to 20 of 24 patients who
had simultaneous sling placement [39]. The
staged approach can be particularly helpful for
patients for whom differentiation between SUI
and urethral post-void dribbling cannot be
achieved. Caution should be taken for placement

98
R. Lee and L. Dreyfuss
of slings for proximal diverticula as increased
intraurethral pressure with Valsalva can cause
rupture of the suture line leading to stula
formation.
De Novo SUI
De novo SUI following urethral diverticulectomy
can occur in up to 17% of patients. A recent prospective series of 100 patients who underwent
video urodynamics prior to diverticulectomy
with modied Martius interposition has found
the rate of de novo SUI to be 16% [10, 32]. Risk
factors for de novo SUI include diverticulum size
(>30mm), proximal location, and complex conguration of the diverticulum on preoperative
imaging [9, 40, 41]. Limited contemporary data
suggest that simultaneous autologous sling placement at the time of diverticulectomy is safe and
may reduce the risk of post-procedural SUI [39].
The decision to offer concurrent SUI treatment
should be balanced with the risk of complications
such as urinary retention, urinary urgency, and
recurrent UTIs [31, 39, 42, 43]. Importantly, con-
comitant use of synthetic mid-urethral slings
should be avoided due to the risk of erosion of the
graft into the urethra [44]. Additionally, it has
been advised that concomitant sling surgery
should be avoided in patients with contraindications to pubovaginal slings, including pure
urgency incontinence, primary bladder neck
obstruction, urethral stricture, and a poorly contractile or acontractile bladder with urinary retention [45].
Management of de novo SUI can be either
conservative or interventional. Conservative
management of postoperative SUI includes pelvic oor muscle training (PFMT), and it can be
expected that the majority of patients who
develop de novo SUI following diverticulectomy
will improve without the need for surgical intervention [32]. In the series published by Barratt
et al., 12 of 16 patients with de novo SUI saw
resolution of symptoms with 3months of pelvic
oor physical therapy [10]. The remaining four
patients underwent video urodynamics (VUDS),
demonstrating distal stricture in one patient,
detrusor overactivity in one patient, and SUI in
two patients.
Surgical management of de novo SUI may be
necessary for a minority (4–10%) of patients
who undergo diverticulectomy [9, 32, 46].
Treatment options include bulking agents or
autologous fascia mid-urethral slings. It must be
stressed again that synthetic materials should
never be used in management of patients with
SUI following urethral diverticulectomy due to
the risk of urethral erosion [44]. It is unknown
whether the risk of erosion decreases with time
or whether synthetic materials may be used in
patients with a remote history of urethral
diverticulectomy.
Urethrovaginal Fistula
Fistula formation following diverticulectomy is
reported in 0–6% of patients. Risk factors for
stula formation include surgery on a recurrent
diverticulum, complexity of the diverticulum,
overlapping suture lines, tension on the incision,
poor mobilization of aps, or poor tissue quality
[6, 47]. Urethrovaginal stula formation distal
to the external urinary sphincter can be mildly
symptomatic, presenting with double voiding or
vaginal voiding. Urethrovaginal stulae proximal to the external urinary sphincter may result
in continuous leakage of urine (Fig. 9.3) [33].
Repair of stula should be delayed until at least
3–6 months following index surgery to allow
time for tissue regrowth [48]. Use of brofatty
labial (Martius) aps is recommended at the
time of repair. As discussed earlier, a Martius
ap may be used at the time of urethral diverticulectomy and may reduce the risk of stula

Urethrovaginal
Vagina
9 Urethral Diverticulectomy
Rectum
Uterus
Bladder
fistula
Urethra
Fig. 9.3 Sagittal view of the female pelvis with a ureterovesical stula. Adapted from Ref. [53]
99
formation with minimal added postoperative
risk [25–27].
Urethral Stricture
Urethral stricture is a rare complication following diverticulectomy and is found in 0–2% of
patients postoperatively. It may be associated
with excision of complex diverticula, particularly
if end-to-end urethroplasty is performed [23].
Presenting symptoms include slow stream, high
post-void residual, or recurrent UTIs. Urethral
strictures can be managed with balloon dilation,
meatotomy, or urethroplasty or conservatively
with clean intermittent catheterization [6, 33, 49].
Recurrent Urethral Diverticulum
Many patients will experience temporary symptoms following urethral diverticulectomy, including pain, dysuria, urgency, and urinary leakage.
The majority of these patients will improve spontaneously without intervention [9]. Persistent
symptoms following diverticulectomy should
raise concern for a residual or recurrent diverticulum and prompt repeat imaging.
Diverticular recurrence is common and can be
found in 2–16% of patients postoperatively [6, 9,
30, 49]. Recurrences are believed to arise from
residual dead space or incomplete excision of the
diverticular sac [50], and recurrence rates are
higher for patients with a history of prior urethral
diverticulectomy. Ingber reported 122 patients
with urethral diverticulectomy that underwent
excision and found that, of the 110 patients without prior urethral diverticulectomy, the rate of
recurrence was 9.1%, compared to 25% (3 of 12)
of patients who were undergoing surgery for a
recurrence. Patients with a history of any pelvic
surgery were also more likely to experience
residual or recurrent diverticula (p<0.001) [35].
It is believed that the complexity of the diverticulum affects outcomes. Han et al. report a
series of 30 women with simple or complex (Cor U-shaped) diverticula. Notably, 0/17 patients
with simple diverticula experienced recurrence
and 7/13 patients with complex diverticula
recurred [34]. Conversely, a series of 43 patients
that underwent diverticulectomy for simple
(n=32) or complex (n=11) diverticula found no

100
R. Lee and L. Dreyfuss
difference in the rates of recurrent diverticula
between the two groups [49]. Recurrent diverticula can be managed similarly to de novo diverticula; asymptomatic recurrences can be managed
with observation while symptomatic recurrences
can be treated with repeat diverticulectomy with
good results [9].
Conclusions
Urethral diverticula represent a benign condition
with potential morbid implications for quality of
life. When indicated, surgical intervention can
lead to resolution of symptoms. However, complications can arise. With a careful surgical technique and proper selection, complications can be
minimized and outcomes improved.
References
1. Marshall S. Urethral diverticula in young girls.
Urology. 1981;17(3):243–5.
2. Ortlip SA, Gonzalez R, Williams RD.Diverticula of
the male urethra. J Urol. 1980;124(3):350–5.
3. Rovner ES.Bladder and female urethral diverticula.
In: Partin AW, editor. Campbell walsh wein urology.
Elsevier; 2021.
4. Rajan N, Tucci P, Mallouh C, Choudhury
M. Carcinoma in female urethral diverticulum:
case reports and review of management. J Urol.
1993;150(6):1911–4.
5. Thomas AA, Rackley RR, Lee U, Goldman HB,
Vasavada SP, Hansel DE. Urethral diverticula in 90
female patients: a study with emphasis on neoplastic
alterations. J Urol. 2008;180(6):2463–7.
6. Ljungqvist L, Peeker R, Fall M. Female urethral
diverticulum: 26-year followup of a large series. J
Urol. 2007;177(1):219–24. discussion 24
7. Aldridge CW, Beaton JH, Nanzig RP. A review of
ofce urethroscopy and cystometry. Am J Obstet
Gynecol. 1978;131(4):432–7.
8. El-Nashar SA, Bacon MM, Kim-Fine S, Weaver
AL, Gebhart JB, Klingele CJ. Incidence of
female urethral diverticulum: a population-based
analysis and literature review. Int Urogynecol J.
2014;25(1):73–9.
9. Stav K, Dwyer PL, Rosamilia A, Chao F. Urinary
symptoms before and after female urethral diverticulectomy--can we predict de novo stress urinary incontinence? J Urol 2008; 180(5): 2088–2090.
10. Barratt R, Malde S, Pakzad M, Hamid R, Ockrim J,
Greenwell T.The incidence and outcomes of urodynamic stress urinary incontinence in female patients
with urethral diverticulum. Neurourol Urodyn.
2019;38(7):1889–900.
11. Baradaran N, Chiles LR, Freilich DA, Rames RA,
Cox L, Rovner ES.Female urethral diverticula in the
contemporary era: is the classic triad of the “3Ds” still
relevant? Urology. 2016;94:53–6.
12. Davis HJ, Telinde RW.Urethral diverticula: an assay
of 121 cases. J Urol. 1958;80(1):34–9.
13. Portnoy O, Kitrey N, Eshed I, Apter S, Amitai
MM, Golomb J. Correlation between MRI and
double-balloon urethrography ndings in the diagnosis of female periurethral lesions. Eur J Radiol.
2013;82(12):2183–8.
14. Chung DE, Purohit RS, Girshman J, Blaivas
JG. Urethral diverticula in women: discrepancies
between magnetic resonance imaging and surgical
ndings. J Urol. 2010;183(6):2265–9.
15. Spencer WF, Streem SB.Diverticulum of the female
urethral roof managed endoscopically. J Urol.
1987;138(1):147–8.
16. Spence HM, Duckett JW. Diverticulum of the
female urethra: clinical aspects and presentation
of a simple operative technique for cure. J Urol.
1970;104(3):432–7.
17. Saito S.Usefulness of diagnosis by the urethroscopy
under anesthesia and effect of transurethral electrocoagulation in symptomatic female urethral diverticula.
J Endourol. 2000;14(5):455–7.
18. Mizrahi S, Bitterman W. Transvaginal, periurethral injection of polytetrauoroethylene (polytef)
in the treatment of urethral diverticula. Br J Urol.
1988;62(3):280.
19. Bodner-Adler B, Halpern K, Hanzal E. Surgical
management of urethral diverticula in women:
a systematic review. Int Urogynecol J.
2016;27(7):993–1001.
20. Welch EK, Dengler KL, Welgoss JA.Urethral diverticulum marsupialization with modied SpenceDuckett procedure. Urology. 2023;
21. Clyne OJ, Flood HD.Giant urethral diverticulum: a
novel approach to repair. J Urol. 2002;167(4):1796.
22. Woodhouse CR, Flynn JT, Molland EA, Blandy
JP. Urethral diverticulum in females. Br J Urol.
1980;52(4):305–10.
23. Rovner ES, Wein AJ.Diagnosis and reconstruction of
the dorsal or circumferential urethral diverticulum. J
Urol. 2003;170(1):82–6. discussion 6
24. Sivarajan G, Glickman L, Faber K, Kim M, Fromer
D, Munver R.Transabdominal robot-assisted laparoscopic urethral diverticulectomy of a complex anterior horseshoe diverticulum of the proximal urethra. J
Endourol Case Rep. 2015;1(1):33–5.
25. Malde S, Sihra N, Naaseri S, Spilotros M, Solomon
E, Pakzad M, et al. Urethral diverticulectomy with
Martius labial fat pad interposition improves symptom resolution and reduces recurrence. BJU Int.
2017;119(1):158–63.
26. Dmochowski R.Urethral diverticula: evolving diagnostics and improved surgical management. Curr Urol
Rep. 2001;2(5):373–8.

9 Urethral Diverticulectomy
101
27. Romanzi LJ, Groutz A, Blaivas JG. Urethral diverticulum in women: diverse presentations resulting
in diagnostic delay and mismanagement. J Urol.
2000;164(2):428–33.
28. Raup VT, Hess DS, Hanske J, Schmid M, Varda B,
Das A, etal. Patient characteristics and perioperative
outcomes of female urethral diverticulectomy (UD):
analysis of a multi-institutional prospective database.
Urology. 2015;86(4):712–5.
29. Ganabathi K, Leach GE, Zimmern PE, Dmochowski
R. Experience with the management of urethral
diverticulum in 63 women. J Urol. 1994;152(5 Pt
1):1445–52.
30. Reeves FA, Inman RD, Chapple CR.Management of
symptomatic urethral diverticula in women: a singleCentre experience. Eur Urol. 2014;66(1):164–72.
31. Swierzewski SJ, McGuire EJ. Pubovaginal sling
for treatment of female stress urinary incontinence complicated by urethral diverticulum. J Urol.
1993;149(5):1012–4.
32. Lee UJ, Goldman H, Moore C, Daneshgari F, Rackley
RR, Vasavada SP.Rate of de novo stress urinary incontinence after urethal diverticulum repair. Urology.
2008;71(5):849–53.
33. Kim HW, Lee JZ, Shin DG. Pathophysiology
and Management of Long-term Complications
after Transvaginal Urethral Diverticulectomy. Int
Neurourol J. 2021;25(3):202–9.
34. Han DH, Jeong YS, Choo MS, Lee KS. Outcomes
of surgery of female urethral diverticula classied using magnetic resonance imaging. Eur Urol.
2007;51(6):1664–70.
35. Ingber MS, Firoozi F, Vasavada SP, Ching CB,
Goldman HB, Moore CK, etal. Surgically corrected
urethral diverticula: long-term voiding dysfunction
and reoperation rates. Urology. 2011;77(1):65–9.
36. Lee RA. Diverticulum of the urethra: clinical presentation, diagnosis, and management. Clin Obstet
Gynecol. 1984;27(2):490–8.
37. Sun Y, Peng B, Wu J, Li Q.Stress urinary incontinence after urethral diverticulum repair without
concomitant anti-incontinence procedure. Urology.
2022;160:229.
38. Bass JS, Leach GE.Surgical treatment of concomitant
urethral diverticulum and stress incontinence. Urol
Clin North Am. 1991;18(2):365–73.
39. Greiman A, Rittenberg L, Freilich D, Rames R,
El-Zawahry A, Koski M, etal. Outcomes of treatment
of stress urinary incontinence associated with female
urethral diverticula: a selective approach. Neurourol
Urodyn. 2018;37(1):478–84.
40. Kim JH, Lee KW, Kim JM, Kim ME, Kim YH.Risk
factors for de novo mixed urinary incontinence and
stress urinary incontinence following surgical removal
of a urethral diverticulum. Low Urin Tract Symptoms.
2013;5(3):154–8.
41. Malde S, Naaseri S, Kavia R, Pakzad M, Hamid R,
Ockrim J, et al. Preliminary report on the effect of
urethral diverticulum magnetic resonance imaging
conguration on the incidence of new onset urodynamic stress urinary incontinence following excision.
Urol Ann. 2017;9(4):321–3.
42. Enemchukwu E, Lai C, Reynolds WS, Kaufman M,
Dmochowski R. Autologous pubovaginal sling for
the treatment of concomitant female urethral diverticula and stress urinary incontinence. Urology.
2015;85(6):1300–3.
43. Bradley SE, Leach DA, Panza J, Sassani J, Escobar
C, Ogorek J, etal. A multicenter retrospective cohort
study comparing urethral diverticulectomy with and
without pubovaginal sling. Am J Obstet Gynecol.
2020;223(2):273.e1–e9.
44. Kobashi KC, Albo ME, Dmochowski RR, Ginsberg
DA, Goldman HB, Gomelsky A, et al. Surgical
treatment of female stress urinary incontinence:
AUA/SUFU guideline. J Urol. 2017;198(4):
875–83.
45. Wein AJ. Re: autologous Pubovaginal sling for the
treatment of concomitant female urethral diverticula
and stress urinary incontinence. J Urol. 2016;195(4 Pt
1):1040–1.
46. Chavez JA, Fuentes JL, Christie AL, Alhalabi F,
Carmel ME, Lemack GE, etal. Stress urinary incontinence after urethral diverticulum repair without
concomitant anti-incontinence procedure. Urology.
2021;154:103–8.
47. Crescenze IM, Goldman HB.Female urethral diverticulum: current diagnosis and management. Curr
Urol Rep. 2015;16(10):71.
48. Greiman AK, Rolef J, Rovner ES. Urethral
diverticulum: a systematic review. Arab J Urol.
2019;17(1):49–57.
49. Nickles SW, Ikwuezunma G, MacLachlan L,
El-Zawahry A, Rames R, Rovner E.Simple vs complex urethral diverticulum: presentation and outcomes. Urology. 2014;84(6):1516–9.
50. Aspera AM, Rackley RR, Vasavada SP.Contemporary
evaluation and management of the female urethral diverticulum. Urol Clin North Am.
2002;29(3):617–24.
51. Working-Group E. Primary urethral cancer 2016.
Available from: https://patients.uroweb.org/cancers/
primary- urethral- cancer/.
52. Raz S. Excision of urethral diverticula. In: Atlas
of vaginal reconstructive surgery. New York, NY:
Springer; 2015.
53. Lue K, Heinsimer K, Madiraju SK, Rideout D,
Wiegand L. Urologic trauma from vaginal dilation
for congenital vaginal stenosis: a newly-described
and challenging complication. Urol Case Rep.
2020;28:101075.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
